ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 66.57

Change

+0.15 (+0.23)%

Market Cap

CAD 0.22B

Volume

1.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.34 (+0.78%)

CAD 3.50B
ZWU:CA BMO Covered Call Utilities ETF

-0.03 (-0.27%)

CAD 1.80B
XIT:CA iShares S&P/TSX Capped Informa..

+1.45 (+2.15%)

CAD 0.89B
TXF:CA First Asset Tech Giants Covere..

+0.35 (+1.75%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

+0.18 (+1.03%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

+0.68 (+0.97%)

CAD 0.56B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.07 (+0.31%)

CAD 0.49B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.02 (+0.07%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.52 (-0.87%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

-0.21 (-0.32%)

CAD 0.26B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.31% 57% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.31% 54% F 54% F
Trailing 12 Months  
Capital Gain -6.24% 14% F 16% F
Dividend Return 0.69% 25% F 8% B-
Total Return -5.55% 9% A- 15% F
Trailing 5 Years  
Capital Gain 15.63% 34% F 44% F
Dividend Return 2.89% 18% F 4% F
Total Return 18.52% 23% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 2.83% 31% F 42% F
Dividend Return 3.24% 17% F 36% F
Total Return 0.41% 26% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 15.53% 66% D+ 54% F
Risk Adjusted Return 20.87% 17% F 34% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.